198 related articles for article (PubMed ID: 9242508)
1. The extracellular domain of BPAG2 localizes to anchoring filaments and its carboxyl terminus extends to the lamina densa of normal human epidermal basement membrane.
Masunaga T; Shimizu H; Yee C; Borradori L; Lazarova Z; Nishikawa T; Yancey KB
J Invest Dermatol; 1997 Aug; 109(2):200-6. PubMed ID: 9242508
[TBL] [Abstract][Full Text] [Related]
2. 97 kDa linear IgA bullous dermatosis antigen localizes in the lamina lucida between the NC16A and carboxyl terminal domains of the 180 kDa bullous pemphigoid antigen.
Ishiko A; Shimizu H; Masunaga T; Yancey KB; Giudice GJ; Zone JJ; Nishikawa T
J Invest Dermatol; 1998 Jul; 111(1):93-6. PubMed ID: 9665393
[TBL] [Abstract][Full Text] [Related]
3. Bullous pemphigoid sera that contain antibodies to BPAg2 also contain antibodies to LABD97 that recognize epitopes distal to the NC16A domain.
Egan CA; Taylor TB; Meyer LJ; Petersen MJ; Zone JJ
J Invest Dermatol; 1999 Feb; 112(2):148-52. PubMed ID: 9989788
[TBL] [Abstract][Full Text] [Related]
4. Cloning of partial cDNA for mouse 180-kDa bullous pemphigoid antigen (BPAG2), a highly conserved collagenous protein of the cutaneous basement membrane zone.
Li K; Guidice GJ; Tamai K; Do HC; Sawamura D; Diaz LA; Uitto J
J Invest Dermatol; 1992 Sep; 99(3):258-63. PubMed ID: 1512460
[TBL] [Abstract][Full Text] [Related]
5. Precise ultrastructural localization of in vivo deposited IgG antibodies in fresh perilesional skin of patients with bullous pemphigoid.
Sato M; Shimizu H; Ishiko A; Masunaga T; Akiyama M; Hashimoto T; Kitajima Y; Nishikawa T
Br J Dermatol; 1998 Jun; 138(6):965-71. PubMed ID: 9747356
[TBL] [Abstract][Full Text] [Related]
6. Internalization of the 180 kDa bullous pemphigoid antigen as immune complexes in basal keratinocytes: an important early event in blister formation in bullous pemphigoid.
Kitajima Y; Nojiri M; Yamada T; Hirako Y; Owaribe K
Br J Dermatol; 1998 Jan; 138(1):71-6. PubMed ID: 9536225
[TBL] [Abstract][Full Text] [Related]
7. The extracellular domain of BPAG2 has a loop structure in the carboxy terminal flexible tail in vivo.
Nonaka S; Ishiko A; Masunaga T; Akiyama M; Owaribe K; Shimizu H; Nishikawa T
J Invest Dermatol; 2000 Nov; 115(5):889-92. PubMed ID: 11069628
[TBL] [Abstract][Full Text] [Related]
8. Decreased mRNA expression of several basement membrane components in basal cell carcinoma.
Chopra A; Maitra B; Korman NJ
J Invest Dermatol; 1998 Jan; 110(1):52-6. PubMed ID: 9424087
[TBL] [Abstract][Full Text] [Related]
9. Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen 2.
Haase C; Büdinger L; Borradori L; Yee C; Merk HF; Yancey K; Hertl M
J Invest Dermatol; 1998 Mar; 110(3):282-6. PubMed ID: 9506450
[TBL] [Abstract][Full Text] [Related]
10. Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin.
Ishiko A; Shimizu H; Kikuchi A; Ebihara T; Hashimoto T; Nishikawa T
J Clin Invest; 1993 Apr; 91(4):1608-15. PubMed ID: 7682575
[TBL] [Abstract][Full Text] [Related]
11. Molecular complexity of the cutaneous basement membrane zone.
Uitto J; Pulkkinen L
Mol Biol Rep; 1996; 23(1):35-46. PubMed ID: 8983017
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning of canine bullous pemphigoid antigen 2 cDNA and immunomapping of NC16A domain by canine bullous pemphigoid autoantibodies.
Xu L; O'Toole EA; Olivry T; Hernandez C; Peng J; Chen M; Chan LS
Biochim Biophys Acta; 2000 Jan; 1500(1):97-107. PubMed ID: 10564722
[TBL] [Abstract][Full Text] [Related]
13. Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen.
Chan LS; Lapiere JC; Chen M; Traczyk T; Mancini AJ; Paller AS; Woodley DT; Marinkovich MP
Arch Dermatol; 1999 May; 135(5):569-73. PubMed ID: 10328198
[TBL] [Abstract][Full Text] [Related]
14. Cicatricial pemphigoid antigen differs from bullous pemphigoid antigen by its exclusive extracellular localization: a study by indirect immunoelectronmicroscopy.
Bédane C; Prost C; Bernard P; Catanzano G; Bonnetblanc JM; Dubertret L
J Invest Dermatol; 1991 Jul; 97(1):3-9. PubMed ID: 2056190
[TBL] [Abstract][Full Text] [Related]
15. Diminished expression of the extracellular domain of bullous pemphigoid antigen 2 (BPAG2) in the epidermal basement membrane of patients with generalized atrophic benign epidermolysis bullosa.
Pohla-Gubo G; Lazarova Z; Giudice GJ; Liebert M; Grassegger A; Hintner H; Yancey KB
Exp Dermatol; 1995 Aug; 4(4 Pt 1):199-206. PubMed ID: 8535614
[TBL] [Abstract][Full Text] [Related]
16. 180-kD bullous pemphigoid antigen/type XVII collagen: tissue-specific expression and molecular interactions with keratin 18.
Aho S; Uitto J
J Cell Biochem; 1999 Mar; 72(3):356-67. PubMed ID: 10022517
[TBL] [Abstract][Full Text] [Related]
17. Difference in binding sites of autoantibodies against 230- and 170-kD bullous pemphigoid antigens on salt-split skin.
Onodera Y; Shimizu H; Hashimoto T; Ishiko A; Ebihara T; Tanaka M; Nishikawa T
J Invest Dermatol; 1994 May; 102(5):686-90. PubMed ID: 8176249
[TBL] [Abstract][Full Text] [Related]
18. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2.
Zone JJ; Taylor TB; Meyer LJ; Petersen MJ
J Invest Dermatol; 1998 Mar; 110(3):207-10. PubMed ID: 9506436
[TBL] [Abstract][Full Text] [Related]
19. IgG anti-LABD97 antibodies in bullous pemphigoid patients' sera react with the mid-portion of the BPAg2 ectodomain.
Egan CA; Reddy D; Nie Z; Taylor TB; Schmidt LA; Meyer LJ; Petersen MJ; Hashimoto T; Marinkovich MP; Zone JJ
J Invest Dermatol; 2001 Feb; 116(2):348-50. PubMed ID: 11180014
[No Abstract] [Full Text] [Related]
20. Autoantibodies from patients with cicatricial pemphigoid target different sites in epidermal basement membrane.
Shimizu H; Masunaga T; Ishiko A; Matsumura K; Hashimoto T; Nishikawa T; Domloge-Hultsch N; Lazarova Z; Yancey KB
J Invest Dermatol; 1995 Mar; 104(3):370-3. PubMed ID: 7861004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
